The Role of Immunity and Inflammation in ME/ CFS and Post-COVID Syndrome: Implications for Treatment.
Comhaire F (2022) The Role of Immunity and Inflammation in […]
Research Papers
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection.
Hohberger B et al. (2021) Case Report: Neutralization of Autoantibodies
Hyperbaric Oxygen Therapy for Long COVID (HOTLoCO), an interim safety report from a randomised controlled trial.
Kjellberg A et al. (2022) Hyperbaric Oxygen Therapy for Long
Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
Kjellberg A et al. (2022) Hyperbaric oxygen for treatment of
Individualizing medical treatment in chronic fatigue syndrome/ myalgic encephalomyelitis: Evidence for effective medications and possible relevance to “Long-Hauler Syndrome” in Covid-19 affected patients.
Levine PH et al. (2022) Individualizing medical treatment in chronic
Efficacy of traditional Chinese exercises in patients with post-COVID-19 chronic fatigue syndrome: A protocol for systematic review and meta-analysis.
Liu Z et al . (2022) Efficacy of traditional Chinese
Transcutaneous Vagus Nerve Stimulation in the Treatment of Long Covid-Chronic Fatigue Syndrome.
Natelson BH et al. (2022) Transcutaneous Vagus Nerve Stimulation in
Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention.
Robbins et al. (2021) Hyperbaric oxygen therapy for the treatment
Epstein-Barr Virus Testing-to-Treatment in Long COVID Patients: A Review and Recommendation.
Shelton AG (2023) Epstein-Barr Virus Testing-to-Treatment in Long COVID Patients:
Non-pharmacological therapies for post-viral syndromes, including Long COVID: A systematic review.
Singh J et al. (2022) Non-pharmacological therapies for post-viral syndromes,
What interventions or best practice are there to support people with Long COVID, or similar post-viral conditions or conditions characterised by fatigue, to return to normal activities: a rapid review.
Spencer LH et al. (2023) What interventions or best practice
Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?
Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID? Read More »
Vink M and Vink-Niese (2022) Is It Useful to Question
Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.
Zilberman-Itskovich S et al. (2022) Hyperbaric oxygen therapy improves neurocognitive
Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach.
Al-Hadrawi DS et al . (2022) Lowered oxygen saturation and
Severity of COVID-19: Causes and Consequences – From Obesity to Chronic Fatigue Syndrome.
Arāja D et al. (2021) Severity of COVID-19: Causes and
Decolonization of staphylococcus aureus and therapeutic test to assist the diagnosis in me/cfs, long covid, post-vaccine covid syndrome and other diseases with fatigue and/or chronic pain.
Chang GA and Figueredo ANT (2023) Decolonization of staphylococcus aureus
Prevalence of Chronic Fatigue Syndrome (CFS) in Korea and Japan: A Meta-Analysis.
Prevalence of Chronic Fatigue Syndrome (CFS) in Korea and Japan: A Meta-Analysis. Read More »
Lim EJ ET al. (2021) Prevalence of Chronic Fatigue Syndrome
Updated ME/CFS prevalence estimates reflecting post-COVID increases and associated economic costs and funding implications.
Mirin AA et al. (2022) Updated ME/CFS prevalence estimates reflecting
The Prevalence, Severity, and Impact of Post-COVID Persistent Fatigue, Post-Exertional Malaise, and Chronic Fatigue Syndrome.
Nehme M et al. (2022) The Prevalence, Severity, and Impact
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways.
Maes M et al. (2022) Lowered Quality of Life in